Table 2.
Clinical outcomes of kidney transplantations
| Clinical Outcomes | All Renal Allografts | Recipients <65 yr | Recipients ≥65 yr | ||||
|---|---|---|---|---|---|---|---|
| Young Donor (<65 yr) DBD | Young Donor (<65 yr) DCD | Young Donor (<65 yr) DBD | Young Donor (<65 yr) DCD | Elderly Donor (≥65 yr) DBD | Elderly Donor (≥65 yr) DCD | ||
| PNF (Yes)a | 259 (7.2%) | 91 (5.3%) | 108 (9.4%) | 15 (8.0%) | 14 (9.8%) | 14 (5.7%) | 17 (12.4%) |
| DGF (Yes)b | 1188 (37.0%) | 306 (19.4%) | 619 (61.7%) | 29 (17.1%) | 87 (69.6%) | 64 (29.2%) | 83 (74.1%) |
| Acute rejection within 3 mo (Yes)c,d | 618 (17.5%) | 287 (17.9%) | 206 (17.9%) | 17 (9.0%) | 13 (9.0%) | 33 (13.5%) | 31 (22.6%) |
| 1-Yr graft survival (%)e,f | 85.8 (84.6 to 87.0) | 88.7 (87.1 to 90.1) | 85.6 (83.4 to 87.5) | 81.9 (75.5 to 86.8) | 79.6 (71.9 to 85.3) | 79.5 (73.7 to 84.1) | 75.3 (67.1 to 81.8) |
| 1-Yr death-censored graft survival (%)e,f | 90.1 (89.1 to 91.1) | 91.9 (90.6 to 93.2) | 88.6 (86.7 to 90.4) | 91.3 (86.7 to 94.8) | 85.3 (79.0 to 90.5) | 89.1 (84.8 to 92.7) | 85.3 (78.7 to 90.6) |
| 1-Yr patient survival (%)e,g | 94.3 (93.4 to 95.0) | 95.8 (94.7 to 96.7) | 95.9 (94.5 to 96.9) | 88.9 (84.4 to 93.5) | 87.7 (81.1 to 92.2) | 88.3 (83.4 to 91.7) | 85.5 (78.2 to 90.5) |
| 5-Yr graft survival (%)e,f | 70.6 (68.9 to 72.2) | 75.4 (73.1 to 77.6) | 72.6 (69.6 to 75.3) | 61.5 (53.3 to 68.7) | 61.9 (52.3 to 70.1) | 52.7 (44.4 to 60.3) | 39.7 (30.0 to 49.3) |
| 5-Yr death-censored graft survival (%)e,f | 84.3 (82.9 to 85.5) | 85.9 (84.1 to 87.6) | 82.6 (80.2 to 84.9) | 87.7 (82.2 to 92.2) | 82.3 (75.4 to 88.3) | 83.8 (78.2 to 88.6) | 75.3 (66.9 to 83.0) |
| 5-Yr patient survival (%)e,g | 79.8 (78.2 to 81.2) | 84.4 (82.3 to 86.2) | 84.2 (81.5 to 86.4) | 68.7 (60.6 to 75.4) | 68.6 (59.2 to 76.3) | 55.0 (46.9 to 62.4) | 50.9 (40.3 to 60.6) |
95% CIs are shown in parentheses.
a
Data available for 3573 patients, after excluding 24 missing values.
b
Data available for 3209 patients, after excluding PNF (n=259) and missing values (n=129).
c
Defined as: no=0 acute rejections; yes= ≥1 acute rejection within 3 months.
d
Data available for 3539 patients (n=58).
e
Data available for 3575 patients, after excluding 22 missing values.
f
Cumulative proportional survival percentages with 95% CIs are shown from cumulative incidence competing risks estimates.
g
Cumulative proportional survival percentages with 95% CIs are shown from the Kaplan–Meier estimates.